Agency Client
Press Archives :
Advisory Clients :
Sadra Medical, Inc.
Company Profile :
Sadra is pioneering significant technical and clinical advancements to an aortic valve replacement procedure called "percutaneous aortic valve replacement" (PAVR), during which a valve prosthesis can be positioned in a patient's heart by means of a catheter navigated through the patient's arteries. PAVR allows a diseased aortic valve to be replaced with a minimally-invasive procedure, thus eliminating the trauma, long recovery times, and attendant risks of open-heart surgery.
Sadra Medical was founded in 2003 by Amr Salahieh, Fred Khosravi and a small group of leading-edge cardiovascular physicians. The company is pioneering new therapies to minimize the invasiveness of treating aortic valve disease. Investors include Accuitive Medical Ventures, Boston Scientific (NYSE: BSX), Finistere, Firstmark Capital, Oakwood, ONSET Ventures, and SV Lifescience.
Date
Category
Document Title
For a live RSS feed of Sadra headlines, click on the feed icon adjacent to "Press Release Archives".
Background Information :
Nothing is yet available. Please call Roeder-Johnson Corporation at +1 (650) 802-1850 to request additional/advance information.
Website :
Additional Contacts :
Press Information :
+1 650.802.1850 x301
+1 650.802.1850 x304